BioSpace News Archive

Mesh Suture, Inc., d.b.a. MSi, announced that it has received 510 clearance from the U.S. Food and Drug Administration for DURAMESH™ non-absorbable polypropylene mesh suture, a pioneering medical device for the surgical closure of soft tissues including muscles, fascia, tendons, and ligaments.

Critical Path Institute named Daniel M. Jorgensen, M.D., MPH, MBA, its Chief Executive Officer.

Foresight Diagnostics, Inc, a leader in cancer diagnostics and cancer relapse testing, announced today that the U.S. Patent and Trademark Office (USPTO) has granted the company patent No.11,447,833 for the detection of minimal residual disease (MRD) using its personalized phased variant detection platform.

PharmaJet today announced that their latest research results will be presented at five upcoming conferences in October.

Neogen Corporation (NASDAQ: NEOG) announced today that Steve Quinlan , the company’s Chief Financial Officer, has announced his intent to retire effective May 31, 2023, at the conclusion of the company’s fiscal year.

The global transthyretin amyloidosis treatment market size was estimated at around USD 4.87 billion in 2021 and it is projected to hit around USD 9.35 billion by 2030, growing at a CAGR of 7.52% from 2022 to 2030.

The global infectious disease in vitro diagnostics market was surpassed at USD 113.7 billion in 2021 and is expected to hit around USD 56.89 billion by 2030, growing at a CAGR of -7.41% from 2022 to 2030.

The global Liver Cancer Diagnostics market size is expected to hit around US$ 20.4 billion by 2030, according to a new report by Vision Research Reports.

The global neuroscience market was reached at US$ 28.3 billion in 2020 and predicted to surpass around US$ 41.4 billion by 2030, expanding at a noteworthy CAGR of 4.1% from 2021 to 2030.

The global Research Antibodies market size is expected to surpass around US$ 16.5 billion by 2030, according to a new report by Vision Research Reports.